Menu

Tonix Pharmaceuticals Holding Corp. TNXP

Full chart Compare
Set alert

Price alert · TNXP

All alert types
4.74 USD +0.14 (+3.04%)

At closeNov 6, 2026, 7:56 PM EST

4.87 +0.13 +2.74%

After hours · Nov 6, 7:56 PM ET

4.63 Day range 4.83
4.60 52-week range 19.89
YTD
-69.65%
1 year
-72.77%

Revenue & Expenses

Other Income → Expenses: $1.68MExpenses → Selling, General & Admin: $85.76MExpenses → Research & Development: $44.49MGross Profit → Expenses: $4.54MRevenue → Gross Profit: $4.54MRevenue → Cost of Revenue: $8.56MNet Loss → Expenses: $124.02MOther Income$1.68MGross Profit$4.54MNet Loss$124.02MCost of Revenue$8.56MExpenses$130.25MSelling, General & Admin$85.76MResearch & Development$44.49MRevenue$13.11M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TNXP annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
13.11M10.09M7.77M00
6.47M2.33M3.03M00
-125.70M-136.70M-118.38M-112.09M-92.31M
-124.02M-130.04M-116.66M-110.22M-92.29M
-14.57-176.60-14,720.25-64,032.00-162,000.00
TNXP annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
207.64M98.78M24.95M120.23M178.66M
277.17M162.89M154.46M225.69M240.90M
32.02M23.33M48.93M18.51M22.18M
1.31M8.12M9.81M760.00K956.00K
245.15M139.56M105.53M207.18M218.72M
TNXP annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-99.84M-60.92M-102.00M-98.05M-75.56M
-4.53M-120.00K-29.07M-48.15M-35.31M
214.53M134.87M36.52M87.84M212.49M
-3.37M-120.00K-6.90M-48.15M-35.31M
110.13M73.83M-94.62M-58.43M101.59M